1. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004
2. Kubicka S, Arkenau H, Grothey A, et al. Randomized trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (mCRC): final results of the safety and efficacy analysis. Presented at: American Society of Clinical Oncology Gastrointestinal Cancers Symposium; January 26-28, 2006; San Francisco, CA. Abstract #277.
3. Randomized phase III trial of the TTD Group comparing capecitabine and oxaliplatin (XELOX) vs. oxaliplatin and 5-fluorouracil in continuous infusion (FUFOX) as first line treatment in advanced or metastatic colorectal cancer (CRC);Massuti;J Clin Oncol,2006
4. Cassidy. European Society for Medical Oncology Congress; September 30-August 1, 2006; Istanbul, Turkey. Abstract #LBA4.